IBDEI1MC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27464,1,3,0)
 ;;=3^Acute Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,27464,1,4,0)
 ;;=4^N10.
 ;;^UTILITY(U,$J,358.3,27464,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,27465,0)
 ;;=N17.8^^106^1362^4
 ;;^UTILITY(U,$J,358.3,27465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27465,1,3,0)
 ;;=3^AKI,Other
 ;;^UTILITY(U,$J,358.3,27465,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,27465,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,27466,0)
 ;;=N17.9^^106^1362^5
 ;;^UTILITY(U,$J,358.3,27466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27466,1,3,0)
 ;;=3^AKI,Unspec
 ;;^UTILITY(U,$J,358.3,27466,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,27466,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,27467,0)
 ;;=R39.2^^106^1362^15
 ;;^UTILITY(U,$J,358.3,27467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27467,1,3,0)
 ;;=3^Pre-Renal Uremia
 ;;^UTILITY(U,$J,358.3,27467,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,27467,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,27468,0)
 ;;=N13.9^^106^1362^14
 ;;^UTILITY(U,$J,358.3,27468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27468,1,3,0)
 ;;=3^Obstructive and Reflux Uropathy,Unspec
 ;;^UTILITY(U,$J,358.3,27468,1,4,0)
 ;;=4^N13.9
 ;;^UTILITY(U,$J,358.3,27468,2)
 ;;=^5015589
 ;;^UTILITY(U,$J,358.3,27469,0)
 ;;=N13.1^^106^1362^11
 ;;^UTILITY(U,$J,358.3,27469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27469,1,3,0)
 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
 ;;^UTILITY(U,$J,358.3,27469,1,4,0)
 ;;=4^N13.1
 ;;^UTILITY(U,$J,358.3,27469,2)
 ;;=^5015576
 ;;^UTILITY(U,$J,358.3,27470,0)
 ;;=N13.2^^106^1362^10
 ;;^UTILITY(U,$J,358.3,27470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27470,1,3,0)
 ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction
 ;;^UTILITY(U,$J,358.3,27470,1,4,0)
 ;;=4^N13.2
 ;;^UTILITY(U,$J,358.3,27470,2)
 ;;=^5015577
 ;;^UTILITY(U,$J,358.3,27471,0)
 ;;=N13.30^^106^1362^13
 ;;^UTILITY(U,$J,358.3,27471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27471,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,27471,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,27471,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,27472,0)
 ;;=N13.39^^106^1362^12
 ;;^UTILITY(U,$J,358.3,27472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27472,1,3,0)
 ;;=3^Hydronephrosis,Other
 ;;^UTILITY(U,$J,358.3,27472,1,4,0)
 ;;=4^N13.39
 ;;^UTILITY(U,$J,358.3,27472,2)
 ;;=^5015579
 ;;^UTILITY(U,$J,358.3,27473,0)
 ;;=R33.9^^106^1362^16
 ;;^UTILITY(U,$J,358.3,27473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27473,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,27473,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,27473,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,27474,0)
 ;;=I75.81^^106^1362^8
 ;;^UTILITY(U,$J,358.3,27474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27474,1,3,0)
 ;;=3^Atheroembolism of Kidney
 ;;^UTILITY(U,$J,358.3,27474,1,4,0)
 ;;=4^I75.81
 ;;^UTILITY(U,$J,358.3,27474,2)
 ;;=^328516
 ;;^UTILITY(U,$J,358.3,27475,0)
 ;;=R34.^^106^1362^7
 ;;^UTILITY(U,$J,358.3,27475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27475,1,3,0)
 ;;=3^Anuria and Oliguria
 ;;^UTILITY(U,$J,358.3,27475,1,4,0)
 ;;=4^R34.
 ;;^UTILITY(U,$J,358.3,27475,2)
 ;;=^5019333
 ;;^UTILITY(U,$J,358.3,27476,0)
 ;;=K76.7^^106^1362^9
 ;;^UTILITY(U,$J,358.3,27476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27476,1,3,0)
 ;;=3^Hepatorenal Syndrome
 ;;^UTILITY(U,$J,358.3,27476,1,4,0)
 ;;=4^K76.7
 ;;^UTILITY(U,$J,358.3,27476,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,27477,0)
 ;;=N00.0^^106^1363^8
 ;;^UTILITY(U,$J,358.3,27477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27477,1,3,0)
 ;;=3^Acute nephritic syndrome w/ minor glomerular abnormality
